Daiichi Sankyo

Companies Daiichi Sankyo

News Daiichi Sankyo

• Provepharm signs license agreement with Daiichi Sankyo to provide methylthioninium chloride Proveblue solution for injection to Japan

  Provepharm announced that it has entered into an exclusive licensing agreement with Daiichi Sankyo to make Provepharm’s injectable medicinal product, Methylthioninium chloride Proveblue, available in Japan. The Proveblue medicinal product is used for the treatment of methaemoglobinaemia induced by l more

• CMC Biologics Announces Agreement with Daiichi Sankyo to Develop and Manufacture Antibodies

  CMC Biologics announces the execution of an agreement with Daiichi Sankyo Co., Ltd. to provide process development support and manufacture of several clinical-stage antibodies over a three-year period. The two companies have recently begun work on thier first joint project at CMC Biologics´Bothell m more

• Pieris and Daiichi Sankyo Sign Therapeutic Collaboration to Develop Anticalin Therapeutics

  Pieris AG announced the signature of a collaboration and license agreement with Daiichi Sankyo Company Limited under which Pieris will apply its proprietary Anticalin scaffold technology to discover novel Anticalins against two Daiichi Sankyo targets. Upon discovery and achievement by Pieris of earl more

Publications Daiichi Sankyo

• Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics

  Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics Content Type Journal Article Pages 1-1 DOI 10.1007/s10928-011-9237-x Authors David Z. D’Argenio, University of Southern California, Los Angeles, CA, USA Marc R. Gastongua more

Market studies Daiichi Sankyo

• Daiichi Sankyo Company, Limited – Product Pipeline Review – 2012

  Introduction Global Market Direct’s pharmaceuticals report, “Daiichi Sankyo Company, Limited - Product Pipeline Review - 2012” provides data on the Daiichi Sankyo Company, Limited’s research and development focus. The report includes information on current developmental pipeline, complete with lat more

• Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Supraventricular Tachycardia (SV more

• Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Venous Thromboembolism Therapeutics mar more

Websites Daiichi Sankyo